- Home
- DNA vs THQ Comparison
DNA vs THQ Comparison
Compare DNA & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- THQ
- Stock Information
- Founded
- DNA 2008
- THQ 2014
- Country
- DNA United States
- THQ United States
- Employees
- DNA N/A
- THQ N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- THQ Finance Companies
- Sector
- DNA Health Care
- THQ Finance
- Exchange
- DNA Nasdaq
- THQ Nasdaq
- Market Cap
- DNA 658.5M
- THQ 763.4M
- IPO Year
- DNA N/A
- THQ N/A
- Fundamental
- Price
- DNA $9.42
- THQ $17.73
- Analyst Decision
- DNA Sell
- THQ
- Analyst Count
- DNA 3
- THQ 0
- Target Price
- DNA $9.67
- THQ N/A
- AVG Volume (30 Days)
- DNA 1.6M
- THQ 158.9K
- Earning Date
- DNA 08-07-2025
- THQ 01-01-0001
- Dividend Yield
- DNA N/A
- THQ 7.53%
- EPS Growth
- DNA N/A
- THQ N/A
- EPS
- DNA N/A
- THQ N/A
- Revenue
- DNA $237,417,000.00
- THQ N/A
- Revenue This Year
- DNA N/A
- THQ N/A
- Revenue Next Year
- DNA $15.91
- THQ N/A
- P/E Ratio
- DNA N/A
- THQ N/A
- Revenue Growth
- DNA 13.76
- THQ N/A
- 52 Week Low
- DNA $5.00
- THQ $15.29
- 52 Week High
- DNA $16.85
- THQ $20.38
- Technical
- Relative Strength Index (RSI)
- DNA 51.44
- THQ 39.10
- Support Level
- DNA $9.75
- THQ $17.71
- Resistance Level
- DNA $13.33
- THQ $18.20
- Average True Range (ATR)
- DNA 0.87
- THQ 0.27
- MACD
- DNA -0.18
- THQ -0.04
- Stochastic Oscillator
- DNA 28.59
- THQ 1.98
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.